Home » Bayer’s Betaferon approved in China for Treatment of Multiple Sclerosis
Bayer’s Betaferon approved in China for Treatment of Multiple Sclerosis
Bayer Schering Pharma AG announced Tuesday that the Chinese
State Food and Drug Administration has approved Betaferon (interferon beta-1b) therapy for patients with relapsing-remitting multiple sclerosis.
Insciences
Insciences
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May